Related Experiment Video
Updated: Jun 27, 2025
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Specific antigens in malignancy-associated membranous nephropathy
Xiaoying Hu1, Guoqin Wang1, Hong Cheng1
1Division of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Abstract:
Membranous nephropathy (MN) is a glomerular disease mediated by autoimmune complex deposition, with approximately 30% of cases attributed to secondary causes. Among them, malignant tumors are a significant cause of secondary MN. Recent advancements in the identification of MN-specific antigens, such as THSD7A and NELL-1, suggest a potential association with malignant tumors, yet definitive proof of this relationship remains elusive. Therefore, this article aims to review the distribution of MN-specific antigens in patients with MN caused by malignant tumors and the possible role of these antigens in the pathogenesis of the disease.
Insights
Membranous nephropathy (MN) linked to cancer involves specific antigens. This review examines antigen distribution and their role in cancer-associated MN pathogenesis.
Area of Science:
- Nephrology
- Oncology
- Immunology
Background:
- Membranous nephropathy (MN) is an autoimmune glomerular disease.
- Malignant tumors are a significant cause of secondary MN, accounting for a notable percentage of cases.
- Specific antigens like THSD7A and NELL-1 are implicated in MN, but their link to cancer-associated MN requires further clarification.
Purpose of the Study:
- To review the distribution of MN-specific antigens in patients with cancer-associated MN.
- To explore the potential role of these antigens in the pathogenesis of malignancy-induced MN.
Main Methods:
- Literature review of studies investigating MN-specific antigens in patients with co-existing malignant tumors.
- Analysis of reported antigen expression patterns and their correlation with tumor types.
Main Results:
- Summarizes findings on the prevalence and types of MN-specific antigens identified in cancer-associated MN.
- Highlights specific antigens frequently found in patients with underlying malignancies.
Conclusions:
- Reinforces the association between specific antigens and cancer-related MN.
- Suggests these antigens may play a crucial role in the development of malignancy-associated membranous nephropathy.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
